# Spectroscopic Imaging at 4T: A Drug Challenge Study

> **NCT01577706** · NA · TERMINATED · sponsor: **Mclean Hospital** · enrollment: 7 (actual)

## Conditions studied

- AOD Effects and Consequences

## Interventions

- **DRUG:** Alprazolam
- **DRUG:** Dextroamphetamine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01577706
- **Lead sponsor:** Mclean Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-06
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** lack of enrollment
- **Last updated:** 2017-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01577706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01577706, "Spectroscopic Imaging at 4T: A Drug Challenge Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01577706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*